Stragen Nordic A/S

• B02 - Antihemorrágicos
• TRANEXAMIC ACID STRAGEN solution for injection 1 000 mg/10 ml
• TRANEXAMIC ACID STRAGEN solution for injection 500 mg/5 ml
• G02 - Otros preparados ginecológicos
• ATOSIBAN STRAGEN concentrate for solution for infusion 37.5 mg/5 ml
• ATOSIBAN STRAGEN solution for injection 6.75 mg/0.9 ml
• G03 - Hormonas sexuales y moduladores del sistema genital
• ZARELLE film-coated tablet 75 µg
• J01 - Antibacterianos para uso sistémico
• CEFOTAXIM STRAGEN powder for solution for injection 1 g
• CEFOTAXIM STRAGEN powder for solution for injection 2 g
• CEFTRIAXON STRAGEN powder for solution for infusion 2 g
• CEFTRIAXON STRAGEN powder for solution for injection 1 g
• CEFTRIAXON STRAGEN powder for solution for injection 500 mg
• CEFUROXIM STRAGEN powder for solution for injection 1.5 g
• CEFUROXIM STRAGEN powder for solution for injection 250 mg
• CEFUROXIM STRAGEN powder for solution for injection 750 mg
• CLOXACILLIN STRAGEN powder for solution for injection 1 g
• CLOXACILLIN STRAGEN powder for solution for injection 2 g
• PIPERACILLIN TAZOBACTAM STRAGEN powder for solution for injection 2 g+0.25 g
• PIPERACILLIN TAZOBACTAM STRAGEN powder for solution for injection 4 g+0.5 g
• N03 - Antiepilépticos
• KEVESY solution for infusion 1 000 mg/100 ml
• KEVESY solution for infusion 1 500 mg/100 ml
• KEVESY solution for infusion 500 mg/100 ml